Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Pediatric clinics of North America

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pcl.2016.04.008PMID 27469182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ursodeoxycholic acid for cystic fibrosis-related liver disease.

  2017cited by this paper
• Pancreatic pathophysiology in cystic fibrosis

  2016cited by this paper
• Gastrointestinal Manifestations of Cystic Fibrosis

  2015cited by this paper
• Intestinal Inflammation and Impact on Growth in Children With Cystic Fibrosis

  2015cited by this paper
• Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis

  2015cited by this paper
• Persistent Fat Malabsorption in Cystic Fibrosis

  2015cited by this paper
• Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients.

  2015cited by this paper
• Rectal Prolapse and Cystic Fibrosis

  2015cited by this paper
• Gastroesophageal Reflux Disease in Children with Cystic Fibrosis.

  2015cited by this paper
• Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO.

  2015cited by this paper
• Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology

  2014cited by this paper
• Non-invasive detection of Helicobacter pylori in cystic fibrosis--the fecal test vs. the urea breath test.

  2014cited by this paper
• Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial

  2014cited by this paper
• Complicated Clostridium difficile colitis in children with cystic fibrosis: association with gastric acid suppression?

  2014cited by this paper
• Cystic fibrosis related diabetes--a new perspective on the optimal management of postprandial glycemia.

  2014cited by this paper
• Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.

  2014cited by this paper
• Ursodeoxycholic acid for cystic fibrosis-related liver disease.

  2014cited by this paper
• Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications

  2014cited by this paper
• The cystic fibrosis intestine.

  2013cited by this paper
• Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States.

  2013cited by this paper
• Gastrostomy in Children With Cystic Fibrosis and Portal Hypertension

  2013cited by this paper
• Gastrointestinal complications of cystic fibrosis.

  2013cited by this paper
• Beta-blocker management of refractory hemoptysis in cystic fibrosis: a novel treatment approach

  2013cited by this paper
• Cystic fibrosis, gastroduodenal inflammation, duodenal ulcer, and H. pylori infection: the "cystic fibrosis paradox" revisited.

  2013cited by this paper
• Recurrent Clostridium difficile colitis in cystic fibrosis: an emerging problem.

  2013cited by this paper
• Outcomes of surgical management of severe GERD in patients with cystic fibrosis

  2013cited by this paper
• Cystic Fibrosis Presenting with Neonatal Cholestasis Simulating Biliary Atresia in a Patient with a Novel Mutation

  2013cited by this paper
• A pilot study of the characterization of hepatic tissue strain in children with cystic-fibrosis-associated liver disease (CFLD) by acoustic radiation force impulse imaging

  2013cited by this paper
• Cirrhosis and other liver disease in cystic fibrosis.

  2013cited by this paper
• Delayed Small Bowel Transit in Children With Cystic Fibrosis and Pancreatic Insufficiency

  2013cited by this paper
• Gastrointestinal transit times and motility in patients with cystic fibrosis

  2012cited by this paper
• Mechanisms of Increased Gastroesophageal Reflux in Patients With Cystic Fibrosis

  2012cited by this paper
• Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.

  2011cited by this paper
• Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice.

  2011cited by this paper
• Colon cancer in lung transplant recipients with CF: increased risk and results of screening.

  2011cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Importance of Hepatic Fibrosis in Cystic Fibrosis and the Predictive Value of Liver Biopsy

  2011cited by this paper
• Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.

  2011cited by this paper
• Issues in the management of simple and complex meconium ileus

  2011cited by this paper
• The Antibacterial Lectin RegIIIγ Promotes the Spatial Segregation of Microbiota and Host in the Intestine

  2011cited by this paper
• Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.

  2011cited by this paper
• Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients.

  2011cited by this paper
• Gastric emptying and different types of reflux in adult patients with cystic fibrosis

  2011cited by this paper
• Intussusception in Adults with Cystic Fibrosis: A Case Series with Review of the Literature

  2011cited by this paper
• Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.

  2011cited by this paper
• Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism

  2010cited by this paper
• Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes

  2010cited by this paper
• Defining DIOS and Constipation in Cystic Fibrosis With a Multicentre Study on the Incidence, Characteristics, and Treatment of DIOS

  2010cited by this paper
• Clinical and Genetic Characteristics of Meconium Ileus in Newborns With and Without Cystic Fibrosis

  2010cited by this paper
• The ESPGHAN Cystic Fibrosis Working Group: defining DIOS and constipation in cystic fibrosis with a multicenter study on the incidence, characteristics, and treatment of DIOS.

  2010cited by this paper
• Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine

  2010cited by this paper
• Cystic fibrosis gene mutations and gastrointestinal diseases.

  2010cited by this paper
• Characteristics of gastroesophageal reflux in adults with cystic fibrosis.

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Persistent elevated tissue‐transglutaminase in cystic fibrosis

  2009cited by this paper
• Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse

  2009cited by this paper
• "Pulling the plug"--management of meconium plug syndrome in neonates.

  2009cited by this paper
• Application of the Glucose Hydrogen Breath Test for the Detection of Bacterial Overgrowth in Patients with Cystic Fibrosis––A Reliable Method?

  2009cited by this paper
• Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients.

  2009cited by this paper
• Genetic modifiers of liver disease in cystic fibrosis.

  2009cited by this paper
• Low Fecal Elastase 1 Levels Do Not Indicate Exocrine Pancreatic Insufficiency in Type-1 Diabetes Mellitus

  2008cited by this paper
• Constipation in pediatric cystic fibrosis patients: an underestimated medical condition.

  2008cited by this paper
• Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation

  2008cited by this paper
• Patterns of GI disease in adulthood associated with mutations in the CFTR gene

  2007cited by this paper
• Potential role for the common cystic fibrosis &Dgr;F508 mutation in Crohn's disease

  2007cited by this paper
• Risk Factors for Small Bowel Bacterial Overgrowth in Cystic Fibrosis

  2007cited by this paper
• Efficacy of Lower Than Standard Doses of Pancreatic Enzyme Supplementation Therapy During Acid Inhibition in Patients With Pancreatic Exocrine Insufficiency

  2006cited by this paper
• Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.

  2006cited by this paper
• Delayed gastric emptying scintigraphy in cystic fibrosis patients before and after lung transplantation.

  2006cited by this paper
• Abdominal manifestations of cystic fibrosis in children

  2006cited by this paper
• Review of the abdominal manifestations of cystic fibrosis in the adult patient.

  2006cited by this paper
• Pancreatitis Among Patients With Cystic Fibrosis: Correlation With Pancreatic Status and Genotype

  2005cited by this paper
• Sonographic Assessment of the Normal Limits and Percentile Curves of Liver, Spleen, and Kidney Dimensions in Healthy School‐Aged Children

  2005cited by this paper
• Early Decline of Pancreatic Function in Cystic Fibrosis Patients with Class 1 or 2 CFTR Mutations

  2005cited by this paper
• Cystic fibrosis.

  2005cited by this paper
• Lactobacillus Sepsis Associated With Probiotic Therapy

  2005cited by this paper
• A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats.

  2005cited by this paper
• Epidemiology of liver disease in cystic fibrosis: a longitudinal study.

  2004cited by this paper
• Appendix in children with cystic fibrosis: US features.

  2004cited by this paper
• Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis

  2004cited by this paper
• Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.

  2003cited by this paper
• Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience.

  2003cited by this paper
• Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas

  2003cited by this paper
• Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome

  2002cited by this paper
• Immunoblot Analysis of Humoral Immune Response to Helicobacter pylori in Children with and without Duodenal Ulcer

  2000cited by this paper
• Seroprevalence of Helicobacter pylori infection in cystic fibrosis and its cross-reactivity with anti-pseudomonas antibodies.

  2000cited by this paper
• Gastrointestinal Manifestations of Cystic Fibrosis

  1999cited by this paper
• Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency

  1998cited by this paper
• High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

  1997cited by this paper
• Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee.

  1995cited by this paper
• Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

  1994cited by this paper
• Crohn's disease and cystic fibrosis

  1994cited by this paper
• Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells.

  1993cited by this paper
• Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis.

  1992cited by this paper
• Cystic Fibrosis Mistaken for Idiopathic Biliary Atresia

  1985cited by this paper
• Clinical and Experimental Gastroenterology Dovepress Enzyme Replacement Therapy for Pancreatic Insufficiency: Present and Future

  year unknowncited by this paper

• Contrast-enhanced multispectral optoacoustic tomography for the assessment of the gastrointestinal transit in patients with cystic fibrosis

  2025cites this paper
• Beyond the mutations: spatiotemporal regulation of CFTR by cAMP and calcium signaling in epithelial physiology and cystic fibrosis

  2025cites this paper
• Cystic Fibrosis Treatment Landscape: Progress, Challenges, and Future Directions

  2025cites this paper
• Prevalence and characteristics of gastrointestinal disorders, medication use, and diagnostic interventions in pediatric patients with cystic fibrosis: a nested case–control analysis from the TriNetX EMR-derived global research network real-world dataset

  2025cites this paper
• Venous Thromboembolism Occurrence and Association with Gastrointestinal Disorders in Children with Cystic Fibrosis: An Analysis from the TriNetX Research Network Global Multicenter Real-World Dataset

  2025cites this paper
• Constipation and DIOS: Diagnosis, differential diagnosis, and management

  2024cites this paper
• A Gastroenterologist’s Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care

  2023cites this paper
• The current state of gastrointestinal motility evaluation in cystic fibrosis: a comprehensive literature review

  2023cites this paper
• Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged >=12 years - The RECOVER study

  2023cites this paper
• Web-Based Survey Piloting Process as a Model for Developing and Testing Past Contraceptive Use and Pregnancy History: Cystic Fibrosis Case Study

  2023cites this paper
• Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years - The RECOVER study.

  2023cites this paper
• D-Lactate: Implications for Gastrointestinal Diseases

  2023cites this paper
• Improving nutrition in cystic fibrosis: A systematic literature review.

  2022cites this paper
• Coming Full Circle: Reflections and Inspirations from a Cystic Fibrosis Patient Scientist Panel

  2022cites this paper
• Epidemiology of Eosinophilic Esophagitis in Patients with Cystic Fibrosis: A Population-Based 5-Year Study

  2022cites this paper
• Pancreatic, hepatobiliary, and gastrointestinal manifestations of children with cystic fibrosis: A 10-year experience from a tertiary care center in southern India

  2022influential citation
• Changes in share wave elastography after Lumacaftor/Ivacaftor treatment in children with cystic fibrosis.

  2022cites this paper
• Non-invasive Diagnostic Tests in Cystic Fibrosis-Related Liver Disease: A Diagnostic Test Accuracy Network Meta-Analysis

  2021cites this paper
• Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis

  2021cites this paper
• Introductory Chapter: Basics of Cystic Fibrosis

  2021cites this paper
• Diagnosing constipation in patients with cystic fibrosis applying ESPGHAN criteria.

  2021cites this paper
• Cystic Fibrosis and Congenital Anomalies of the Exocrine Pancreas

  2021cites this paper
• PROCEEDINGS OF THE 17thITALIAN CONVENTION OF FFC INVESTIGATORS IN CYSTIC FIBROSIS

  2020cites this paper
• Prevalence of constipation in cystic fibrosis patients: a systematic review of observational studies

  2020cites this paper
• CFTR dysregulation drives active selection of the gut microbiome

  2020cites this paper
• Review of Cystic Fibrosis.

  2019cites this paper
• Gastrointestinal, Pancreatic, and Hepatic Manifestations of Cystic Fibrosis in the Newborn.

  2019cites this paper
• Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions

  2019cites this paper
• Cystic Fibrosis: Clinical Phenotypes in Children and Adolescents

  2018influential citation
• Cystic Fibrosis Disease Modifiers: Complex Genetics Defines the Phenotypic Diversity in a Monogenic Disease.

  2018cites this paper
• epatobiliary disease in children and adolescents ith cystic fibrosis

  2018cites this paper
• Modulating Hallmarks of Cholangiocarcinoma

  2018cites this paper
• The role of stem cells in cystic fibrosis disease modeling and drug discovery

  2018cites this paper
• Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data

  2018cites this paper
• Personalized or Precision Medicine? The Example of Cystic Fibrosis

  2017cites this paper
• Abordagem nutricional na Fibrose Quística em idade pediátrica.

  2017cites this paper
• An update on new and emerging therapies for cystic fibrosis

  2017cites this paper
• Hepatobiliary disease in children and adolescents with cystic fibrosis.

  2017cites this paper
• Recurrent Pneumonia in Children: A Reasoned Diagnostic Approach and a Single Centre Experience

  2017cites this paper